ASX-listed Shekel Brainweigh gains on higher H1 revenue
** Shares of Israel-based weighing technology developer
Shekel Brainweigh SBW.AX climb as much as 6.1% to A$0.105, set
to snap a three-day losing streak
** Says H1 total revenue gains 23% to $13.1 million on
strong performance of its healthcare segment urn:newsml:reuters.com:*:nASXSbVnd
** Stock has lost over half its value YTD, as of last close
(Reporting by Harshita Swaminathan)
((Harshita.Swaminathan@thomsonreuters.com))
Recent news on Shekel Brainweigh
See all newsBrief: Shekel Brainweigh Says Shareholders Approved Removal From Official List Of ASX
ASX-listed Shekel Brainweigh jumps on Q4 revenue growth
Brief: Shekel Brainweigh Posts Revenue US$7.65M In Q4-2024
Brief: Shekel Brainweigh Says ASX Confirmed It Had Agreed To Remove Shekel From Official List
Brief: Shekel Brainweigh Requests Trading Halt Pending Delisting Announcement